Exome Asset Management »

Eli Lilly & Co. shares owned by Exome Asset Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.8M 9.7k 905.38
2024-03-31 $7.5M 9.7k 777.96
2023-12-31 $5.7M 9.7k 582.92

More positions owned by Exome Asset Management

Eli Lilly & Co. (LLY)
Sarepta Therapeutics (SRPT)
Beigene Sponsored Adr (BGNE)
Tg Therapeutics (TGTX)
Cigna Corp (CI)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Insmed Com Par $.01 (INSM)
Amgen (AMGN)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Avadel Pharmaceuticals Com Shs (AVDL)
Dex (DXCM)
Autolus Therapeutics Spon Ads (AUTL)
Intuitive Surgical Com New (ISRG)
Dr Reddys Labs Adr (RDY)

View all positions for Exome Asset Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation
Jennison Associates
Bank of New York Mellon

View all funds holding Eli Lilly & Co.